|

Orticumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BI204, MLDL1278a

Pipeline

Phase 2: 1

Top Sponsors

  • Abcentra1

Indications

  • Atherosclerotic Coronary Vascular Disease1
  • Myocardial Infarct1
  • Acute Coronary Syndromes1
  • Coronary Arterial Disease (CAD)1
  • Heart Disease1

Los Angeles, California1 trial

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

Abcentra Investigational Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.